SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: bob zagorin who wrote (28671)4/12/1999 8:41:00 PM
From: Cacaito  Read Replies (1) | Respond to of 32384
 
Cylexin development stopped on 3/30/97. Cytel licensed if from Ligand.

Cylexin is a p-selectin inhibitor for the prevention of reperfusion injury after transplants, phase III in children showed poor results.

Cylexin is from the research area of former Glycomed (one of the parts of Ligand).